⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Official Title: A Phase II, Non-randomized, Multi-center Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) in Subjects With Advanced Non-Small Cell Lung Cancer

Study ID: NCT00549328

Study Description

Brief Summary: This study is designed to evaluate the efficacy and safety of monotherapy pazopanib (a small molecule tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3, PDGF, and c-kit) in subjects with advanced (Stage IIIB or IV) non-small cell lung cancer.

Detailed Description: Study 109609 is a single-arm, non-randomized, single-stage Phase II study of pazopanib in subjects with Stage IIIB or IV non-small cell lung cancer who have progressed after one or two prior regimens of systemic therapy. The study will be conducted at a limited number of institutions in the US. A total of 40 evaluable subjects will be enrolled and treated. Pazopanib will be given at a dose of 800mg (as determined by previous Phase I studies) orally once per day. Subjects may continue to receive study drug for up to two years unless they experience disease progression or withdraw from treatment for other reasons, or unless the Sponsor terminates the study. A rollover study may be available to those subjects who are exhibiting clinical benefit (stable disease or better). Evaluable subjects will be assessed for response as the primary endpoint.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

GSK Investigational Site, Scottsdale, Arizona, United States

GSK Investigational Site, Fort Myers, Florida, United States

GSK Investigational Site, Orlando, Florida, United States

GSK Investigational Site, Baton Rouge, Louisiana, United States

GSK Investigational Site, Duluth, Minnesota, United States

GSK Investigational Site, Buffalo, New York, United States

GSK Investigational Site, Columbus, Ohio, United States

GSK Investigational Site, Tulsa, Oklahoma, United States

GSK Investigational Site, Philadelphia, Pennsylvania, United States

GSK Investigational Site, Sayre, Pennsylvania, United States

GSK Investigational Site, Corpus Christi, Texas, United States

GSK Investigational Site, Newport News, Virginia, United States

GSK Investigational Site, Seattle, Washington, United States

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: